AstraZeneca plc (LON:AZN) had its Sell rating reiterated by UBS Group

Analyst Ratings For AstraZeneca plc (LON:AZN)

Story continues below

Today, UBS Group reiterated its Sell rating on AstraZeneca plc (LON:AZN).

There are 10 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AstraZeneca plc (LON:AZN) is Hold with a consensus target price of GBX 6,688.24 per share, a potential .

Some recent analyst ratings include

  • 8/21/2019-AstraZeneca plc (LON:AZN) had its Sell rating reiterated by UBS Group
  • 8/20/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital
  • 8/20/2019-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Liberum Capital

    Recent Trading Activity for AstraZeneca plc (LON:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 7,334.00 up +65.00 0.89% with 44.94 shares trading hands.

    An ad to help with our costs